Decision Support Study: A web-based intervention to reduce decision conflict regarding HIV pre-exposure prophylaxis

Although African, Caribbean and Black (ACB) patients make up only 4.7% of Ontario’s population, they represent 30% of Canada’s population living with HIV, and 25% of all new HIV cases in Canada. Rates of new HIV infections can be brought down with HIV Pre-Exposure Prophylaxis (PrEP), a medication that has proven extremely effective at preventing HIV infections when it is taken correctly. Unfortunately, PrEP uptake remains insufficient, especially amongst at-risk individuals. Moreover, most research concerning PrEP tends to focus on improving adherence to PrEP and little is known about the decisions ACB patients make while they are considering whether to start a PrEP regimen.